Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:12 PM ET 8-K
M&A Deal UL Solutions Inc. ULS

UL Solutions M&A Deal with Eurofins Scientific SE

UL Solutions Inc. has completed the acquisition of the electrical and electronics (E&E) business of Eurofins Scientific SE. The deal expands UL Solutions' global footprint and testing, inspection, and certification (TIC) capabilities across EMEA, Asia, and the United States, specifically in electromagnetic compatibility, wireless testing, and medical devices.

Counterparty
Eurofins Scientific SE
4:11 PM ET 8-K
Product Launch Linkhome Holdings Inc. LHAI

Linkhome Holdings Product Launch

Linkhome Holdings launched GPU Marketplace 2.0, a public platform allowing customers to rent AI computing capacity from distributed individuals and data centers. The marketplace supports high-end NVIDIA GPUs like the H100 and B200, aiming to improve GPU utilization and provide flexible alternatives to dedicated hardware. This launch represents a key step in the commercialization of the company's AI computing business.

4:11 PM ET 8-K/A
M&A Deal Baker Hughes Co BKR

Baker Hughes M&A Deal with Chart Industries, Inc.

Baker Hughes Company filed an amendment to its previous 8-K to provide required financial statements and pro forma information following its completed acquisition of Chart Industries, Inc. The acquisition was executed for an initial purchase price of $210 per share, with Chart surviving as an indirect subsidiary of Baker Hughes. As part of the regulatory approval process, the company agreed to divest Chart’s Integrated Pre-cooled Single Mixed Refrigerant (IPSMR) business.

Counterparty
Chart Industries, Inc.
4:10 PM ET 8-K
Capital Raise Carlyle Private Equity Partners Fund, L.P.

Carlyle Private Equity Partners Fund Capital Raise of $300M

Carlyle Private Equity Partners Fund, L.P. sold unregistered limited partnership units to investors for aggregate consideration of approximately $299.9 million on September 1, 2026. The sale was conducted as part of the Fund's continuous private offering across multiple unit classes, including Class E-A, E-I, S, I, and C.

Value
$300M
4:08 PM ET 8-K
M&A Deal Liquidity Services Inc LQDT

Liquidity Services Signs $80M M&A Deal with Auction Holdings, Inc.

Liquidity Services acquired Auction Holdings, Inc., the operator of the Invaluable, AuctionZip, and RFC Auction Systems marketplaces, for a base purchase price of $80 million in cash. The acquisition expands Liquidity Services' global footprint in the collectibles, fine art, and antiques markets by integrating Invaluable's technology platform and global buyer base. The transaction was completed on October 1, 2026, using cash on hand.

Value
$80M
Counterparty
Auction Holdings, Inc.

“Our shared goal is to help Invaluable’s auction-house customers innovate and grow their business by strengthening the technology, services and buyer-engagement tools available to them. By combining Invaluable’s category leadership with Liquidity Services’ proven marketplace operating and merchandising capabilities, we will create meaningful value for auction houses, buyers and shareholders.”

Bill Angrick, Chairman and CEO of Liquidity Services

“Joining Liquidity Services will allow us to accelerate our product roadmap in areas such as shipping and payments, lean into AI to unlock new efficiencies and experiences, expand global demand, and deliver the best possible platform for both bidders and auction houses.”

Brett Malone, CEO of Invaluable
4:07 PM ET 8-K
M&A Deal Hope Bancorp Inc HOPE

Hope Bancorp M&A Deal with Commercial Banking Unit of SMBC MANUBANK

Hope Bancorp's subsidiary, Bank of Hope, has completed its acquisition of the Commercial Banking Unit of SMBC MANUBANK from SMBC Americas Holdings. The deal includes the activation of a collaboration agreement where Bank of Hope will provide financial services to SMBC's Japan-based middle-market and retail customers operating in the U.S.

Counterparty
Commercial Banking Unit of SMBC MANUBANK
4:02 PM ET 8-K
Capacity Expansion Edible Garden AG Inc EDBL

Edible Garden AG Capacity Expansion: $6.33M Investment

Edible Garden entered into a contract to acquire its 6.2-acre Prairie Hills manufacturing facility in Webster City, Iowa, for $6.325 million. The acquisition transitions the company from tenant to owner of a strategic site being developed into a 100+ million unit ready-to-drink (RTD) manufacturing platform. The deal is financed through a combination of Series B Preferred Stock and a $3.825 million secured promissory note.

Value
$6.33M
Counterparty
Iowa Shrimp Holdings, LLC
4:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Lantern Pharma Inc. LTRN

Lantern Pharma Nasdaq/NYSE Compliance Notice

Lantern Pharma Inc. received a deficiency notice from Nasdaq on September 25, 2026, for failing to maintain a minimum market value of listed securities (MVLS) of $35 million for 30 consecutive business days. The company has 180 calendar days, or until March 24, 2027, to regain compliance by maintaining an MVLS of at least $35 million for 10 consecutive business days.

Counterparty
Nasdaq
Term
180 days
4:00 PM ET 8-K
Capital Raise Jefferies Credit Partners BDC Inc.

Jefferies Credit Partners BDC Capital Raise of $106M

Jefferies Credit Partners BDC Inc. completed an unregistered sale of approximately 7.44 million Class I common shares to third-party investors. The transaction generated gross proceeds of approximately $106.5 million based on the company's net asset value (NAV) per share as of August 31, 2026. The offering was conducted as a private placement exempt from registration under Section 4(a)(2) and Regulation D/S.

Value
$106M
Counterparty
certain third-party investors
3:52 PM ET 8-K
Capital Raise Warburg Pincus Access Fund, L.P.

Warburg Pincus Access Fund Capital Raise of $12M

Warburg Pincus Access Fund, L.P. sold unregistered limited partnership units for aggregate consideration of approximately $12.0 million on September 1, 2026. The sale was conducted as part of the Fund's continuous private offering and included Class B1, B3, and E units sold at their respective Transactional NAVs.

Value
$12M
Counterparty
Third-party investors and Independent Directors
3:51 PM ET 8-K
Divestiture Mangoceuticals, Inc. MGRX

Mangoceuticals Divestiture to Two accredited investors for $2.5M

Mangoceuticals, Inc. sold a 25% ownership stake in its subsidiary, MangoRx IP Holdings, LLC, to two accredited investors for $2.5 million. The transaction was structured at the subsidiary level to raise capital for the commercialization of its antiviral technology (MGX-0024) without diluting the parent company's common stock.

Value
$2.5M
Counterparty
Two accredited investors
2:00 PM ET 8-K
Licensing Deal DarkPulse, Inc. DPLS

DarkPulse Licensing Deal with Department of the Air Force, Air Force Research Laboratory

DarkPulse, Inc. has executed an exclusive U.S. patent license agreement with the U.S. Air Force Research Laboratory for a package of six patents. The licensed technologies cover satellite power-sharing, laser systems, constellation navigation, and hybrid terrestrial-satellite networking, which the company intends to use to develop a space-based power grid.

Counterparty
Department of the Air Force, Air Force Research Laboratory
11:31 AM ET 8-K
Capital Raise Alpha Modus Holdings, Inc. AMOD

Alpha Modus Holdings Capital Raise of $250M

Alpha Modus Holdings closed a PIPE transaction with non-U.S. investors, issuing 51,621,560 shares and warrants in exchange for 3,170 bitcoin valued at over $250 million. The company believes this capital raise restores its compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million, addressing a previous deficiency notice.

Value
$250M
Counterparty
Non-U.S. investors
11:16 AM ET 8-K
M&A Deal JLL Income Property Trust, Inc. ZIPTAX

JLL Income Property Trust Signs $90M M&A Deal with Worcester Distribution Center

JLL Income Property Trust acquired the Worcester Distribution Center, a 396,000-square-foot Class A industrial building in the Western Boston submarket, for approximately $90 million. The property is 100% leased to a single tenant and features specialized storage buildouts including refrigeration and automation. This acquisition increases the company's industrial portfolio to $2.7 billion, representing 39% of its total assets.

Value
$90M
Counterparty
Worcester Distribution Center
9:16 AM ET 8-K
M&A Deal Plum Acquisition Corp. IV PLMK

Plum Acquisition Corp. IV M&A Deal with Controlled Thermal Resources Holdings Inc.

Plum Acquisition Corp. IV provided a status update on its pending business combination with Controlled Thermal Resources (CTR), announcing agreements to convert approximately $245 million of CTR's debt into equity and PIPE financing upon closing. The restructuring is designed to simplify the capital structure and strengthen the balance sheet ahead of the combined company's expected Nasdaq listing in Q4 2026. The deal supports CTR's development of the Hell’s Kitchen geothermal power and critical minerals project.

Counterparty
Controlled Thermal Resources Holdings Inc.
9:16 AM ET 8-K
Clinical Trial Data Gain Therapeutics, Inc. GANX

Gain Therapeutics Clinical Trial Data

Gain Therapeutics presented 12-month open-label extension data from its Phase 1b study of rexaceract, showing stabilization of MDS-UPDRS motor scores in Parkinson’s disease patients. The data suggests disease-modifying potential as patients showed no clinically meaningful progression of motor symptoms over the one-year period. The company plans to submit a Phase 2 protocol to the FDA and initiate a Phase 2 trial in Q1 2027.

Term
12 months
9:01 AM ET 8-K
Regulatory Approval NovoCure Ltd NVCR

NovoCure Regulatory Approval

NovoCure received approval from Japan's Ministry of Health, Labour and Welfare for its Optune Pax device to treat adult patients with unresectable locally advanced pancreatic cancer. The approval was based on Phase 3 PANOVA-3 trial results showing statistically significant improvement in median overall survival. This marks a major commercial milestone for the company in Japan, where pancreatic cancer is the fourth leading cause of cancer death.

Counterparty
Ministry of Health, Labour and Welfare (MHLW)
9:01 AM ET 8-K
M&A Deal La Rosa Holdings Corp. SRTM

La Rosa Holdings M&A Deal with NVIDIA B300 GPUs

La Rosa Holdings acquired latest-generation NVIDIA B300 GPUs as part of a strategic pivot into AI infrastructure and leased them back to generate recurring revenue. Alongside the acquisition, the company appointed Chairman Nicholas Adler as CEO to lead a transformation that includes evaluating the divestiture of its legacy real estate operations.

Counterparty
NVIDIA B300 GPUs
Term
long-term
8:30 AM ET 8-K
Partnership Evolution Metals & Technologies Corp. EMAT

Evolution Metals & Technologies Partnership with VIVIFY Technology Corporation

Evolution Metals & Technologies (EMAT) signed a non-binding letter of intent with VIVIFY Technology to form a strategic energy collaboration. VIVIFY will serve as the primary hydrogen energy technology partner and infrastructure provider for EMAT's planned U.S. rare earth magnet campus. The partnership aims to provide behind-the-meter, near-zero-emission power to support power-intensive critical materials processing.

Counterparty
VIVIFY Technology Corporation
8:30 AM ET 8-K
M&A Deal Nsts Bancorp, Inc. NSTS

Nsts Bancorp Signs $73.7M M&A Deal with Brookfield Bancshares, Inc.

NSTS Bancorp, Inc. completed its merger with Brookfield Bancshares, Inc., with NSTS merging into Brookfield and its subsidiary bank becoming a wholly-owned subsidiary of Brookfield. Shareholders of NSTS received $14.31 per share in cash, representing an aggregate merger consideration of approximately $73.7 million. As a result of the transaction, NSTS common stock has been delisted from the Nasdaq Capital Market.

Value
$73.7M
Counterparty
Brookfield Bancshares, Inc.
8:21 AM ET 8-K
Capital Raise Banzai International, Inc. PARA

Banzai International Capital Raise

Banzai International entered into a subscription agreement with its CEO and Chairman, Joseph Davy, for the private placement of 115,965 shares of Class B Common Stock. The shares were sold at $0.70 per share for an aggregate cash purchase price of approximately $81,176. Following the transaction, Mr. Davy maintains a 25.6% voting interest in the company.

Counterparty
Joseph Davy
8:20 AM ET 8-K
M&A Deal Bnb Plus Corp. BNBX

Bnb Plus M&A Deal with Comstock Multichain Fund and KGPLA Holdings LLC

BNB Plus Corp. entered into a second amendment to its Registration Rights Agreement with holders of its registrable securities, including Comstock Multichain Fund and KGPLA Holdings LLC. The amendment removes the mandatory filing deadline for a resale registration statement and replaces it with a demand-based obligation, while also waiving any prior failures by the company to meet its registration obligations.

Counterparty
Comstock Multichain Fund and KGPLA Holdings LLC
8:16 AM ET 8-K
M&A Deal SpyGlass Pharma, Inc. SGP

SpyGlass Pharma Signs $13M M&A Deal with Advanced Vision Science, Inc.

SpyGlass Pharma acquired 100% of the equity of Advanced Vision Science, Inc. (AVS) from Santen Holdings US for approximately $13 million in cash. The deal secures internal manufacturing capacity for the intraocular lenses (IOL) used in SpyGlass's Phase 3 drug delivery system and includes a supply agreement to continue providing products to Santen in Japan.

Value
$13M
Counterparty
Advanced Vision Science, Inc.
8:11 AM ET 8-K
Clinical Trial Data Azitra, Inc. AZTR

Azitra Clinical Trial Data

Azitra, Inc. has completed Cohort 1 of its Phase 1/2 clinical trial for ATR-04, a live biotherapeutic candidate for treating skin rash associated with EGFR inhibitors. Following a safety review committee clearance, the company is proceeding to enroll approximately 24 patients in Cohort 2 to further evaluate safety, tolerability, and preliminary efficacy.

8:02 AM ET 8-K
Clinical Trial Data Evommune, Inc. EVMN

Evommune Clinical Trial Data

Evommune presented Phase 2a proof-of-concept data for EVO301 in patients with moderate-to-severe atopic dermatitis, showing a 55% mean reduction in EASI scores at Week 12 compared to 22% for placebo. The trial validated IL-18 inhibition as a novel therapeutic approach with a favorable safety profile, and the company plans to initiate a Phase 2b dose-ranging trial in mid-2027.

Counterparty
European Academy of Dermatology and Venereology (EADV)
8:01 AM ET 8-K
Divestiture Radnostix Inc INIS

Radnostix Divestiture to Nano Nuclear Energy Inc. for $13.5M

Radnostix Inc. entered into a definitive agreement to sell its depleted uranium deconversion and fluorine extraction assets, including an NRC license and related patents, to Nano Nuclear Energy Inc. for $13.5 million. The consideration consists of $9.5 million in cash and $4 million in Nano Nuclear restricted common stock, allowing Radnostix to focus on its core radioisotope technology segments.

Value
$13.5M
Counterparty
Nano Nuclear Energy Inc.
7:59 AM ET 8-K
Clinical Trial Data Nektar Therapeutics NKTR

Nektar Therapeutics Clinical Trial Data

Nektar Therapeutics announced long-term Phase 2b data for rezpegaldesleukin in patients with alopecia areata (REZOLVE-AA) and atopic dermatitis (REZOLVE-AD) at the EADV Congress 2026. The data demonstrated sustained hair regrowth and deepening of response even six months after treatment cessation, suggesting a differentiated regulatory T cell (Treg) mechanism compared to existing systemic therapies.

Earnings call
Oct 1, 2026, 3:00 PM ET
7:55 AM ET 8-K
M&A Deal Armada Acquisition Corp. II XRPNU

Armada Acquisition Corp. II M&A Deal with Ripple Labs Inc.

Armada Acquisition Corp. II shareholders approved the business combination with Ripple Labs Inc. and Pathfinder Digital Assets LLC at an extraordinary general meeting. The transaction involves a merger and domestication of the company from the Cayman Islands to Delaware, where it will be renamed Arrington Capital SPAC I Inc. Approximately 69% of the shares entitled to vote were represented at the meeting to approve the deal.

Counterparty
Ripple Labs Inc.
7:51 AM ET 8-K
Capital Raise Veritone, Inc. VERI

Veritone Capital Raise of $15M

Veritone, Inc. entered into a securities purchase agreement for a registered direct offering of 20,000,000 shares of common stock at an implied price of $0.75 per share. The company expects to raise $15.0 million in gross proceeds to repay or restructure convertible debt and for general corporate purposes. The offering is expected to close on or about October 2, 2026.

Value
$15M
7:46 AM ET 8-K
Capital Raise Brightline Interactive, Inc. BTLN

Brightline Interactive Capital Raise of $1.25M

Brightline Interactive closed a private investment in public equity (PIPE) raising $1.25 million in gross proceeds through the issuance of units of common stock and warrants. The financing was led by drone industry executive Dr. Allan Evans in his personal capacity to support the development of the SpatialCore Physical AI platform.

Value
$1.25M
Counterparty
Dr. Allan Evans

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.